The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Diabetes in Asia and the Pacific: Implications for the Global Epidemic
Abstract
The last three decades have witnessed an epidemic rise in the number of people with diabetes, especially type 2 diabetes, and particularly in developing countries, where more than 80% of the people with diabetes live. The rise of type 2 diabetes in South Asia is estimated to be more than 150% between 2000 and 2035. Although aging, urbanization, and associated lifestyle changes are the major determinants for the rapid increase, an adverse intrauterine environment and the resulting epigenetic changes could also contribute in many developing countries. The International Diabetes Federation estimated that there were 382 million people with diabetes in 2013, a number surpassing its earlier predictions. More than 60% of the people with diabetes live in Asia, with almost one-half in China and India combined. The Western Pacific, the world’s most populous region, has more than 138.2 million people with diabetes, and the number may rise to 201.8 million by 2035. The scenario poses huge social and economic problems to most nations in the region and could impede national and, indeed, global development. More action is required to understand the drivers of the epidemic to provide a rationale for prevention strategies to address the rising global public health “tsunami.” Unless drastic steps are taken through national prevention programs to curb the escalating trends in all of the countries, the social, economic, and health care challenges are likely to be insurmountable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Self-citationGlobal estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · cited 20×
“Furthermore, the study by Yajnik (76) in India strongly suggest that early development issues and epigenetics may play an important role in the contemporary burden of diabetes experienced in India.”
BackgroundInfluentialSelf-citationPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708473 · Cited by 3,898 · cited 2×
“The effect of the intrauterine environment and the resulting epigenetic changes may also convey increased risk of T2DM and other chronic diseases in adult life (1,7).”
BackgroundType 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
Hales, C. N., & Barker, D. J. P. (1992) · Diabetologia · doi:10.1007/bf00400248 · Cited by 3,309
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Prevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Cited by
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
Teo, Z. L., Tham, Y.-C., Yu, M., Chee, M. L., Rim, T. H., Cheung, N., Bikbov, M. M., Wang, Y. X., Tang, Y., Lu, Y., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.04.027 · Cited by 2,420
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Olsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J. A., Damasceno, A., Delles, C., Gimenez-Roqueplo, A.-P., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 939
Ranasinghe, P., Mathangasinghe, Y., Jayawardena, R., Hills, A. P., & Misra, A. (2017) · BMC Public Health · doi:10.1186/s12889-017-4041-1 · Cited by 746
Lim, R. B. T., Wee, W. K., For, W. C., Ananthanarayanan, J. A., Soh, Y. H., Goh, L. M. L., Tham, D. K. T., & Wong, M. L. (2020) · BMC Public Health · doi:10.1186/s12889-019-7969-5 · Cited by 602
Epidemiology of diabetes and diabetic complications in China
Ma, R. C. W. (2018) · Diabetologia · doi:10.1007/s00125-018-4557-7 · Cited by 491
Self-citationAn Update on the Epidemiology of Type 2 Diabetes
Tinajero, M. G., & Malik, V. S. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.013 · Cited by 471
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
Kosiborod, M., Lam, C. S. P., Kohsaka, S., Kim, D. J., Karasik, A., Shaw, J., Tangri, N., Goh, S.-Y., Thuresson, M., Chen, H., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.009 · Cited by 461
Self-citationAmbient air pollution and diabetes: A systematic review and meta-analysis
Yang, B.-Y., Fan, S., Thiering, E., Seissler, J., Nowak, D., Dong, G.-H., & Heinrich, J. (2020) · Environmental Research · doi:10.1016/j.envres.2019.108817 · Cited by 353
Prevalence of chronic kidney disease in Asia: a systematic review and analysis
Liyanage, T., Toyama, T., Hockham, C., Ninomiya, T., Perkovic, V., Woodward, M., Fukagawa, M., Matsushita, K., Praditpornsilpa, K., Hooi, L. S., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-007525 · Cited by 345
Prevalence and clinical significance of diabetes in asian versus white patients with heart failure
Bank, I. E. M., Gijsberts, C. M., Teng, T.-H. K., Benson, L., Sim, D., Yeo, P. S. D., Ong, H. Y., Jaufeerally, F., Leong, G. K. T., Ling, L. H., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2016.09.015 · Cited by 87
Epidemiology of Diabetes—Status of a Pandemic and Issues Around Metabolic Surgery
Zimmet, P. Z., & Alberti, K. G. M. M. (2016) · Diabetes Care · doi:10.2337/dc16-0273 · Cited by 64
Self-citationUmphonsathien, M., Prutanopajai, P., Aiam‐O‐Ran, J., Thararoop, T., Karin, A., Kanjanapha, C., Jiamjarasrangsi, W., & Khovidhunkit, W. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.956 · Cited by 44
“Type 2 diabetes mellitus (DM) is considered a growing pandemic with a rapid increase in the number of patients in both developed and developing countries (Jayawardena et al., 2012; Nanditha et al., 2016; Yang et al., 2016).”
Background
Metadata
- Authors
- Nanditha, A., Ma, R. C. W., Ramachandran, A., Snehalatha, C., Chan, J. C. N., Chia, K. S., Shaw, J. E., & Zimmet, P. Z.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-02-12
- Volume
- 39
- Issue
- 3
- Pages
- 472-485
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2279419135
- Cited by
- 487
- References
- 101
- FWCI
- 43.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.